REQUEST A DEMO
Total
USD $0.00
Search more companies

G&R Pharmedica S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Data Processing, Hosting, and Related Services | Management Consulting Services | All Other Business Support Services | All Other Schools and Instruction
Full name: G&R Pharmedica S.R.O. Profile Updated: July 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

G&R Pharmedica S.R.O. is a company in Slovakia, with a head office in Nove Zamky. It operates in the Pharmacies and Drug Stores industry. The company was established on September 30, 2014. G&R Pharmedica S.R.O. currently employs 10 - 19 (2025) people. In 2024, the company reported a net sales revenue increase of 13.49%. Over the same period, its total assets grew by 5.12%. The net profit margin of G&R Pharmedica S.R.O. decreased by 0.38% in 2024.

Headquarters
L. Stura, 18
Nove Zamky; Nitriansky; Postal Code: 94060

Contact Details: Purchase the G&R Pharmedica S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the G&R Pharmedica S.R.O. report to view the information.
Registered Capital:
Purchase the G&R Pharmedica S.R.O. report to view the information.
Financial Auditors:
Purchase the G&R Pharmedica S.R.O. report to view the information.
Incorporation Date:
September 30, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after G&R Pharmedica S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
13.49%
Total operating revenue
12.32%
Operating profit (EBIT)
-10.18%
EBITDA
-6.77%
Net Profit (Loss) for the Period
-17.11%
Total assets
5.12%
Total equity
17.14%
Operating Profit Margin (ROS)
-0.44%
Net Profit Margin
-0.38%
Return on Equity (ROE)
-6.05%
Debt to Equity Ratio
-31.78%
Quick Ratio
-0.07%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?